摘要:
A method for positioning a work, which is adapted for a knock hole of a small diameter and which can absorb a pitch error between a main positioning hole and an auxiliary positioning hole of the work is disclosed. An insert shaft of a main positioning device is inserted into the main positioning hole. An auxiliary positioning device includes a base lower block having a parallel slide holding surface, a sliding flange having a sliding surface, and an insert shaft disposed above the sliding flange. The sliding flange of the auxiliary positioning device is guided and moved by the slide holding surface, and is inserted, while absorbing the pitch error, into the auxiliary positioning hole, thereby to position the work.
摘要:
Intended is to provide a method for positioning a work (15), which is adapted for a knock hole of a small diameter and which can absorb a pitch error between a main positioning hole (16) and an auxiliary positioning hole (17) of the work (15). An insert shaft (21) of main positioning means 820) is inserted into the main positioning hole (16). Auxiliary positioning means (30) includes a base lower block (36) having a parallel slide holding surface (36e), a sliding flange (34b) having a sliding surface (34c), and an insert shaft (31) disposed above the sliding flange (34b). The sliding flange (34b) of the auxiliary positioning means (30) is guided and moved by the slide holding surface (36e), and is inserted, while absorbing the pitch error, into the auxiliary positioning hole (17), thereby to position the work (15).
摘要:
The present invention provides to a novel compound having an ACAT inhibiting activity.The present invention relates to compounds represented by formula (I) wherein represents an optionally substituted divalent residue such as benzene, pyridine, cyclohexane or naphthalene, or a group, Het represents a 5- to 8-membered, substituted or unsubstituted heterocyclic group containing at least one heteroatom selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, such as a monocyclic group, a polycyclic group or a group of a fused ring, X represents —NH—, an oxygen atom or a sulfur atom, Y represents —NR4—, an oxygen atom, a sulfur atom, a sulfoxide or a sulfone, Z represents a single bond or —NR5—, R4 represents a hydrogen atom, a lower alkyl group, an aryl group or an optionally substituted silyl lower alkyl group, R5 represents a hydrogen atom, a lower alkyl group, an aryl group or an optionally substituted silyl lower alkyl group, and n is an integer of from 1 to 15, or salts or solvates thereof, and a pharmaceutical composition containing at least one of these compounds.
摘要:
Compounds having the formula (1): wherein R1 represents an alkyl or alkenyl group, R2 and R3 each independently represent a hydrogen atom or an alkyl, hydroxyalkyl, dihydroxyalkyl or alkynyl group, or R2 and R3 may be fused together with the adjacent nitrogen atom to form a substituted or unsubstituted, nitrogen-containing, saturated heterocyclic group, X, Y and Z each independently represent a hydrogen atom, an alkyl group, a halogen atom or the like, and n stands for an integer of from 1 to 5; and also to medicinal compositions containing them. These compounds have inhibitory activity against IL-1β production, high water solubility and good oral absorbability.
摘要:
A phenylpyridazine derivative represented by the formula (1): Wherein, R1, R2, R3, X, Y, Z and n have the same meaning as defined in the specification; or a salt thereof, or a medicine containing the compound. The present invention provides water-soluble phenylpyridazine derivatives and medicines containing them, which have excellent inhibitory activity against interleukin-β production, high water solubility and high oral absorbability.
摘要:
This invention relates to pyridazine derivatives represented by the formula (1): wherein R1 represents a (substituted) aryl group, R2 represents a phenyl group substituted at 4-position by a lower alkoxyl group or a lower alkylthio group, R3 represents a lower alkoxyl group, a halogenated lower alkyl group, a lower cycloalkyl group, a (subsituted) aryl group, a (substituted) aryloxy group, a (substituted) nitrogen-containing heterocyclic ring residue, a (substituted) aminocarbonyl group or a lower alkylcarbonyl group, A represents a single bond, a lower alkylene group or a lower alkenylene group, X represents O or S, and the dashed line indicates that the carbon-carbon bond between the 4-position and the 5-position is a single bond or a double bond, or salts thereof; and also to medicines containing them as effective ingredients. These compounds have excellent inhibitory activity against interleukin-1β production, and are useful as preventives and therapeutics for immune system diseases, inflammatory diseases, ischemic diseases and the like.
摘要:
A fuel injection amount calculation method calculates a fuel injection amount to an internal combustion engine of a vehicle. The method can include calculating a relative intake pressure which is a difference between an intake pressure peak of intake air upon intake starting of a cylinder of the internal combustion engine and an intake pressure bottom of the intake air upon intake ending. The method can also include calculating the fuel injection amount based on the relative intake pressure.
摘要:
In a vehicle outside rearview mirror device including a mirror housing capable of tilting with respect to a vehicle body, the vehicle outside rearview mirror device includes a base fixed to the vehicle body; a shaft fixed to the base; and the mirror housing mounted to the shaft so as to be capable of tilting, wherein a wall that reduces a flow rate of a wind passing through a gap between the base and the mirror housing is provided to the shaft.
摘要:
Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin. Specifically disclosed is and EPO production enhancer and/or a hemoglobin production enhancer comprising a 1-acyl-4-(substituted oxy, substituted amino, or substituted thio)-1,2,3,4-tetrahydroquinoline derivative, more specifically a tetrahydroquinoline compound represented by general formula (1) [wherein R1, R2, R2′, R3 and R3′ independently represent a hydrogen atom, a C1-6 alkyl group, or the like; R4, R5, R6, R7, R8, R9 and R10 independently represent a hydrogen atom, a halogen atom, a C1-6 alkyl group, or the like; A represents N—R11, a sulfur atom, or an oxygen atom; R11 represents a hydrogen atom, a C1-6 alkyl group, or the like; B represents a C6-14 aryl group, or a 5- to 10-membered heterocyclic group; and n represents an integer of 0 or 1], a salt of the tetrahydroquinoline compound, or a solvate of the tetrahydroquinoline compound or the salt.
摘要翻译:公开了具有低分子量且具有增强EPO产生活性和/或提高血红蛋白生成活性的化合物。 具体公开的是EPO生产增强剂和/或包含1-酰基-4-(取代的氧基,取代的氨基或取代的硫代)-1,2,3,4-四氢喹啉衍生物,更具体地是四氢喹啉化合物的血红蛋白生成增强剂 由通式(1)表示[其中R1,R2,R2',R3和R3'独立地表示氢原子,C1-6烷基等; R 4,R 5,R 6,R 7,R 8,R 9和R 10独立地表示氢原子,卤素原子,C 1-6烷基等; A表示N-R11,硫原子或氧原子; R 11表示氢原子,C 1-6烷基等; B表示C 6-14芳基或5至10元杂环基; n表示0或1的整数],四氢喹啉化合物的盐或四氢喹啉化合物或其盐的溶剂合物。
摘要:
This invention relates to pyridazine derivatives represented by the formula (1): wherein R1 represents a (substituted) aryl group, R2 represents a phenyl group substituted at 4-position by a lower alkoxyl group or a lower alkylthio group, R3 represents a lower alkoxyl group, a halogenated lower alkyl group, a lower cycloalkyl group, a (substituted) aryl group, a (substituted) aryloxy group, a (substituted) nitrogen-containing heterocyclic ring residue, a (substituted) aminocarbonyl group or a lower alkylcarbonyl group, A represents a single bond, a lower alkylene group or a lower alkenylene group, X represents O or S, and the dashed line indicates that the carbon-carbon bond between the 4-position and the 5-position is a single bond or a double bond, or salts thereof; and also to medicines containing them as effective ingredients. These compounds have excellent inhibitory activity against interleukin-1β production, and are useful as preventives and therapeutics for immune system diseases, inflammatory diseases, ischemic diseases and the like.